TIAA Trust National Association Has $866,000 Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

TIAA Trust National Association boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 15.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,457 shares of the biotechnology company’s stock after buying an additional 191 shares during the period. TIAA Trust National Association’s holdings in Axon Enterprise were worth $866,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. Prestige Wealth Management Group LLC raised its stake in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise during the fourth quarter valued at $40,000. Brooklyn Investment Group purchased a new stake in Axon Enterprise in the 3rd quarter worth about $41,000. Y.D. More Investments Ltd acquired a new stake in Axon Enterprise during the 4th quarter worth about $45,000. Finally, Stonebridge Financial Group LLC purchased a new position in Axon Enterprise during the 4th quarter valued at about $53,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Down 1.5 %

AXON opened at $550.65 on Friday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business has a 50 day moving average price of $590.80 and a 200 day moving average price of $546.79. The firm has a market cap of $42.19 billion, a P/E ratio of 142.29, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. TD Cowen initiated coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. Needham & Company LLC reissued a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. Robert W. Baird upped their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Finally, JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $604.67.

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.